|
Thursday, April 22, 2021 |
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect |
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. more info >> |
|
Friday, March 12, 2021 |
|
Avance臨床客戶Atossa Therapeutics宣布了第一階段臨床研究的最終結果,該研究表明針對COVID-19研發的AT-301鼻噴霧劑的安全性和耐受性 |
澳大利亞領先的生物技術CRO和Frost&Sullivan亞太CRO市場領導獎獲得者Avance Clinical祝賀Atossa Therapeutics宣布了他們為COVID-19開發的AT-301鼻噴霧劑的第一階段最終結果。 more info >> |
|
Avance临床客户Atossa Therapeutics宣布了第一阶段临床研究的最终结果,该研究表明针对COVID-19研发的AT-301鼻喷雾剂的安全性和耐受性 |
more info >> |
|
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 |
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. more info >> |
|
Friday, February 26, 2021 |
|
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones |
The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. more info >> |
|
Friday, October 30, 2020 |
|
아방스 클리니컬, 마스터 컨트롤 2020 혁신 우수상 수상 |
호주의 바이오테크 임상수탁기관(CRO) 선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 2020 아시아태평양 CRO 마켓 리더십 어워드(2020 Asia-Pacific CRO Market Leadership Award)을 수상한 바 있는 아방스 클리니컬은 오늘 열린 온라인 수상식에서 마스터 컨트롤 2020(MasterControl 2020) 혁신 우수상(Innovation Excellence Award)을 수상했다. more info >> |
|
Avance Clinical Wins MasterControl 2020 Innovation Excellence Award |
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. more info >> |
|
Avance Clinical榮獲MasterControl 2020創新卓越獎 |
澳大利亞領先的生物技術CRO以及Frost&Sullivan 2020年亞太CRO市場領導獎的獲得者,Avance Clinical今天在虛擬儀式上接受了MasterControl 2020創新卓越獎。 more info >> |
|
Avance Clinical荣获MasterControl 2020创新卓越奖 |
澳大利亚领先的生物技术CRO以及Frost&Sullivan 2020年亚太CRO市场领导奖的获得者,Avance Clinical今天在虚拟仪式上接受了MasterControl 2020创新卓越奖。 more info >> |
|
Wednesday, October 28, 2020 |
|
Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020 |
Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. more info >> |
|
|
|